• 'Regarding Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography'
• A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System
• A hospitalist's approach to managing acute kidney injury (hepatorenal syndrome) in cirrhosis
• A Retrospective Cohort Study From the National Inpatient Sample Database (2016-2019): Does Obesity Affect the Outcomes of Hospitalization Due to Hepatocellular Carcinoma?
• A Review of Terlipressin in Hepatorenal Syndrome: Targeting Endothelial Dysfunction and Subsequent Cardiovascular Adverse Events
• Acute kidney injury and point-of-care ultrasound in liver cirrhosis: redefining hepatorenal syndrome
• Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance
• Acute kidney injury in acute liver failure: A narrative review
• Acute Kidney Injury in Chronic Liver Disease in Northwest India: Still a Battle to Conquer
• Acute kidney injury in patients with Cirrhosis: Acute disease quality Initiative (ADQI) and international Club of ascites (ICA) joint multidisciplinary consensus meeting
• Advances in the management of complications from cirrhosis
• Albumin: a comprehensive review and practical guideline for clinical use
• Analysis of clinical characteristics and risk factors for nosocomial mortality in patients with liver cirrhosis combined with atrial arrhythmia
• Apheresis Techniques for the Treatment of Hyperbilirubinemia in the Nephrology Unit
• Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites
• Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis
• B-Blockers in Liver Cirrhosis: A Wonder Drug for Every Stage of Portal Hypertension? A Narrative Review
• Bedside assessment of sarcopenia in hospitalized patients with liver cirrhosis: Magnitude and clinical implications
• Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial
• Characteristics and Related Factors of Bacterial Infection Among Patients With Cirrhosis
• Chinese guidelines on the management of ascites in cirrhosis : Chinese Society of Hepatology, Chinese Medical Association
• Cholemic Nephropathy: Role in Acute Kidney Injury in Cholestasis and Cirrhosis
• Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis
• Comparative Study of Treatment Outcome with Tenofovir Alafenamide and Entecavir in Patients with HBV Related Acute on Chronic Liver Failure
• Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure-acute kidney injury - an open label RCT
• Controversies in terlipressin and transplantation in the United States: How do we MELD the two?
• Corrigendum to "Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure"
• Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings
• Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study
• Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study)
• Effect of midodrine on HVPG in advanced chronic liver disease and acute-on-chronic liver failure-A pilot study
• Effects of <em>Portulaca oleracea</em> (purslane) on liver function tests, metabolic profile, oxidative stress and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: a randomized, double-blind clinical trial
• Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis
• Erratum: Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial: Erratum
• From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury
• Glycyrrhizin attenuates renal inflammation in a mouse Con A-hepatitis model via the IL-25/M2 axis
• Gut microbiome and metabolome signatures in liver cirrhosis-related complications
• Gut-Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers
• Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury
• Helicobacter pylori Infection and Complications of Cirrhosis
• Hepato-Cardio-Renal Syndrome
• Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?
• Hepatorenal syndrome in the intensive care unit
• Hepatorenal Syndrome Type 1: Diagnosis and Treatment
• High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study
• Importance about use of high-throughput sequencing in pediatric: case report of a patient with Fanconi-Bickel syndrome
• Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment Regimens
• Intraoperative hemodialysis with supra- and infradiaphragmatic catheters for liver transplantation
• Key Components of Successful Management of Acute Fatty Liver of Pregnancy: A Case Report and Literature Review
• Kidney involvement in Wilson's disease: a review of the literature
• Letter to the Editor: Is right heart assessment vital for evaluating Terlipressin-related outcomes in Hepatorenal Syndrome-AKI?
• Letter to the Editor: Regarding terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury
• Liver cirrhosis and complications from the perspective of dysbiosis
• Liver cirrhosis as a multisystem disease
• Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
• Long-Circulating Vasoactive 1,18-Octadecanedioic Acid-Terlipressin Conjugate
• Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2
• Malnutrition Severity Predicts Clinical Outcomes in Alcoholic Hepatitis: Evidence from National Data
• Management of hepatorenal syndrome and associated outcomes: a systematic reviews
• Management of hepatorenal syndrome and treatment-related adverse events
• Mortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• Nonalcoholic Fatty Liver Disease and Ethnicity: Lessons Learned from the Arab Population in Israel
• Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium
• Pathophysiology of Hepatorenal Syndrome
• Pay attention to the diagnosis and treatment of "easily neglected" complications in liver cirrhosis
• Point-of-care ultrasound permits early initiation of terlipressin in suspected hepatorenal syndrome-acute kidney injury: A single arm proof-of-concept report
• Portal Hypertension among Patients with Chronic Liver Disease Admitted to the Department of Internal Medicine of a Tertiary Care Centre
• Prognostic nutritional index application value for acute-on-chronic liver failure co-infection
• Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis
• Regarding terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury
• Renal Complications in Portal Hypertension
• Renal Replacement Therapy in Cirrhosis: A Contemporary Review
• Renal resistive index measurements by ultrasound in patients with liver cirrhosis: Magnitude and associations with renal dysfunction
• Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in Hepatorenal Syndrome-AKI ?
• Reply:Regarding terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury
• Research Progress in the Roles of Sympathetic Nervous System in Liver Cirrhosis and Its Complications
• Retraction Note: Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-kappaB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals
• Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
• Role of albumin infusion in cirrhosis-associated complications
• Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis
• Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population
• Safety of Nonselective Beta-Blockers in Decompensated Liver Cirrhosis and Their Role in Inducing Hepatorenal Syndrome
• Seeing and Sensing the Hepatorenal Syndrome (HRS): The Growing Role of Ultrasound-Based Techniques as Non-Invasive Tools for the Diagnosis of HRS
• Severe Hyponatremia Associated With Terlipressin Use in Esophageal Variceal Bleeding
• Shortening the albumin challenge from 48 to 24 hours may lead to overdiagnosis of hepatorenal syndrome-acute kidney injury and overtreatment with terlipressin
• Sound waves and solutions: Point-of-care ultrasonography for acute kidney injury in cirrhosis
• Study of prevalence, risk factors for acute kidney injury, and mortality in liver cirrhosis patients
• Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) coinfected with COVID-19 complicated by hemophagocytic lymphohistiocytosis: a case report
• Teduglutide-induced acute gastric mucosal necrosis in short bowel syndrome with hepatorenal failure: Case report
• Terlipressin for hepatorenal syndrome
• The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients
• Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities
• Transplant Trial Watch
• Turmeric-induced Liver Injury
• Use of Terlipressin in AKI Associated Hepatorenal Syndrome: CON
• Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY
• Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO
• Validating new coding algorithms to improve identification of alcohol-associated and nonalcohol-associated cirrhosis hospitalizations in administrative databases
• Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
• When should a liver disease patient be admitted to the intensive care unit?